Robert S

Biography

Mr. Robert S. Radie, also known as Bob, has been the Chief Executive Officer and President of Egalet Corporation since March 2012. Mr. Radie served as the Chief Executive Officer and President of Sanofi-Topaz Inc. (formerly, Topaz Pharmaceuticals, Inc.) from November 17, 2010 to October 2011. He served as the Chief Executive Officer and President of TransMolecular, Inc. from April 2009 to November 2010 and also served as its Full-Time Business Development Consultant from December 2008 to March 2009. He served as the Chief Business Officer and Executive Vice President of Prestwick Pharmaceuticals, Inc. from August 23, 2007 to September 2008. He played leading roles in the acquisition of Prestwick by Biovail Corp. in 2008 and Morphotek by Eisai, Inc. in 2007. He served as the Chief Business Officer and Vice President of Project Management at Morphotek Inc. He served as the Senior Vice President of Sales of Vicuron Pharmaceuticals, Inc., since March 9, 2004. He served as the Senior Vice President of Strategic Projects & Planning at Vicuron Pharmaceuticals, Inc. He spent his professional career in positions of increasing responsibility at Eli Lilly and Company. His tenure at Eli Lilly was marked by management of several successful product launches and leadership of national sales forces and served as Director of Sales for its Critical Care Division. He served the positions at Eli Lilly as District Manager, Operations Manager, Marketing Associate and Sales Representative, consistently leading his territories in sales performance and oversaw the entire U.S. deployment for the division, which included a team of 231 sales representatives and 23 district managers. 

Research Interest

He served as the Director of Sales for the diabetes business unit's top-performing northeast region and launched three new products, including Actos(R) and Humalog Mix 75/25(R). He has almost 30 years of experience in the Pharmaceutical and Biotechnology Industry. He has been an Outside Director of Paratek Pharmaceuticals, Inc. since October 30, 2014, Pennsylvania Bio since May 2015 and Egalet Corporation since March 2012. He has been an Independent Director since July 27, 2016. He has been a Director of Horse Power For Life since 2007. He served as a Director of Affinium Pharmaceuticals, Ltd. since July 2012. He served as a Director of Sanofi-Topaz Inc. Mr. Radie holds a Bachelor of Science degree in Chemistry from Boston College.